Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Natural Products

Background:

• Global population aging is increasing the incidence of cardio-cerebrovascular diseases (CVDs), making them a leading cause of mortality.
• Borneol (BO), a natural compound, exhibits various beneficial properties including anti-inflammatory, anti-oxidant, anti-apoptotic, and anti-coagulant activities.
• BO can enhance drug delivery across physiological barriers like the blood-brain barrier (BBB), mucous membranes, and skin.

Purpose of the Study:

• To summarize the pharmacological actions of borneol (BO) on cardio-cerebrovascular diseases (CVDs).
• To explore the potential mechanisms underlying BO's therapeutic effects on CVDs.
• To provide novel insights for the development of CVD treatments utilizing BO.

Main Methods:

• Literature review of existing studies on borneol (BO) and its effects on cardio-cerebrovascular diseases (CVDs).
• Analysis of pharmacological activities such as anti-inflammatory, anti-oxidant, anti-apoptotic, and anti-coagulant properties.
• Investigation into BO's role in improving energy metabolism and drug delivery across physiological barriers.

Main Results:

• Borneol (BO) demonstrates significant therapeutic potential for various CVDs.
• BO possesses multiple pharmacological actions beneficial for cardiovascular health.
• BO's ability to enhance drug penetration across barriers is a key aspect of its therapeutic utility.

Conclusions:

• The pharmacological actions and mechanisms of borneol (BO) in treating CVDs warrant further comprehensive investigation.
• Borneol (BO) presents promising avenues for novel therapeutic strategies against cardio-cerebrovascular diseases.
• Understanding BO's mechanisms can lead to improved drug delivery and treatment efficacy for CVDs.